CALMARK SWEDEN AB has a total of 22 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Sweden, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, biotechnology and medical technology are B BIO CO LTD, WU HUAN-PING and ALL MEDICUS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Sweden | 7 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | India | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Chemical engineering | |
#6 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Karlsson Mathias | 13 |
#2 | Lundh Michael | 7 |
#3 | Didrikson Hjalmar | 7 |
#4 | Hiort Af Ornaes Sofia | 7 |
#5 | De Araújo Silva Ana Catarina | 6 |
#6 | Söderlund Anna | 5 |
#7 | Svahn Johan Gustav | 4 |
#8 | De Arteaga Sebastian | 4 |
#9 | Ornaes Sofia Hiort Af | 4 |
#10 | Eriksson Nils Olof | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020011552A1 | A method of detecting the presence of a biomarker in a sample of a flowable substance, a detector assembly for use in the detection of a biomarker in a sample of a flowable substance and a detector unit for use in the detection of the presence of a biomarker in a sample of a flowable substance | |
SE1850880A1 | Detection of the presence of bilirubin in a sample of a flowable substance | |
SE1850879A1 | Detection of the presence of a biomarker in a sample of a flowable substance | |
CN110494751A | The detection of biomarker in the sample of flowable mass | |
JP2015121559A | Testing system for determining hypoxia induced cellular damage | |
US2014329262A1 | Testing system and method for testing | |
CN104040321A | Testing system arrangement and method for testing | |
WO2012036622A1 | System and method for analyzing risk or presence of organ failure |